🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pilot Immunotherapy Study of Combination Prostate Specific Membrane Antigen...
Status
Completed
Location
H. Lee Moffitt Cancer Center & Research Institute
Start Date
2008-12-02
Trial ID
NCT00694551
Treatments Being Tested
This study is for adult patients with advanced melanoma who are receiving i...
Status
Recruiting
Location
University of Virginia
Start Date
2024-09-27
Trial ID
NCT06472661
Treatments Being Tested
The incidence of melanoma is increasing with an estimated incidence of 59,9...
Status
Completed
Location
New York University Langone Medical Center
Start Date
2010-09
Trial ID
NCT01079741
Treatments Being Tested
A safety study to compare the effect of two different formulations of PrEP-...
Status
Completed
Location
Quotient Clinical
Start Date
2017-05-08
Trial ID
NCT03198676
Treatments Being Tested
This is a multicenter, phase 2b, open-label, non-randomized, clinical trial...
Status
Active Not Recruiting
Location
Soroka Medical Center
Start Date
2024-05-27
Trial ID
NCT06422936
Treatments Being Tested
When multi-kinase inhibitors based therapies (sorafenib and regorafenib) ar...
Status
Unknown
Location
The second affiliated hospital of Zhejiang University
Start Date
2018-10-22
Trial ID
NCT03732547
This phase I trial studies the side effects and immune response to DEC-205/...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2013-07-30
Trial ID
NCT01834248
Treatments Being Tested
This is a partially blinded randomized controlled phase II pilot study comp...
Status
Recruiting
Location
Icahn School of Medicine at Mount Sinai (ISMMS)
Start Date
2024-01-16
Trial ID
NCT06343077
Treatments Being Tested
This is an early phase I, single-arm, open-label clinical study designed to...
Status
Recruiting
Location
Biogenea Pharmaeuticals Ltd
Start Date
2026-02-02
Trial ID
NCT07328087
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of SL-701...
Status
Completed
Location
University of Alabama
Start Date
2014-05
Trial ID
NCT02078648